Petros Pharmaceuticals, Inc. Short-Term Debt
Petros Pharmaceuticals, Inc. (PTPI) had Short-Term Debt of $1.74 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2022-03-31
- 2021-09-30: Debt, Current $1.74M.
- 2021-06-30: Debt, Current $3.43M.
- 2021-03-31: Debt, Current $5.06M.
- 2020-12-31: Debt, Current $7.18M.
| Period end | Debt, Current |
|---|---|
| 2021-09-30 | $1.74M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.43M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $5.06M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $7.18M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |